Literature DB >> 28500738

Occurrence and predictors of acute stent recoil-A comparison between the xience prime cobalt chromium stent and the promus premier platinum chromium stent.

Rutger J van Bommel1, Miguel E Lemmert1, Nicolas M van Mieghem1, Robert-Jan van Geuns1, Ron T van Domburg1, Joost Daemen1.   

Abstract

OBJECTIVES: To compare the occurrence of acute stent recoil in two different stent types (platinum chromium and cobalt chromium) and identify the potential predictors of significant acute stent recoil.
BACKGROUND: Acute stent recoil is frequently observed after percutaneous coronary intervention and has been associated with in-stent restenosis and in-stent thrombosis. Different stent designs may result in varying degrees of stent recoil.
METHODS: From a registry of "all-comers" treated with either the Xience Prime Cobalt Chromium or Promus Premier Platinum Chromium stent, a random sample of 100 patients was drawn. Acute stent recoil was defined as the minimal luminal diameter (MLD) of the last inflated balloon minus the MLD after, divided by the MLD of the last inflated balloon. Significant acute stent recoil was defined as recoil ≥10%.
RESULTS: A total of 123 lesions (61 Xience Prime vs 62 Promus Premier) in 100 patients were analyzed. Acute stent recoil of 8.6 ± 4.9% was observed in the Xience Prime group versus 8.7 ± 4.2% in the Promus Premier group, P = 0.970. In a multivariate model for significant acute stent recoil, a stent/vessel ratio ≥1 (hazard ratio 4.64 [1.94-11.12], P = 0.001), a balloon/stent ratio >1 (hazard ratio 3.83 [1.12-13.14], P = 0.032) and direct stenting (hazard ratio 0.42 [0.18-0.96], P = 0.039) were identified as predictors.
CONCLUSIONS: No significant differences were observed in the extent of acute stent recoil between the Xience Prime and the Promus Premier stent. A larger stent/vessel ratio, a larger balloon/stent ratio, and direct stenting were associated with significant acute stent recoil ≥10%.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  drug-eluting stent; quantitative coronary angiography; stent design/structure/coatings

Mesh:

Substances:

Year:  2017        PMID: 28500738     DOI: 10.1002/ccd.27096

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  4 in total

1.  3D-Printed Sugar-Based Stents Facilitating Vascular Anastomosis.

Authors:  Ali Farzin; Amir K Miri; Fatemeh Sharifi; Negar Faramarzi; Arian Jaberi; Azadeh Mostafavi; Ricky Solorzano; Yu Shrike Zhang; Nasim Annabi; Ali Khademhosseini; Ali Tamayol
Journal:  Adv Healthc Mater       Date:  2018-10-30       Impact factor: 9.933

2.  Serial invasive imaging follow-up of the first clinical experience with the Magmaris magnesium bioresorbable scaffold.

Authors:  Maria Natalia Tovar Forero; Laurens van Zandvoort; Kaneshka Masdjedi; Roberto Diletti; Jeroen Wilschut; Peter P de Jaegere; Felix Zijlstra; Nicolas M Van Mieghem; Joost Daemen
Journal:  Catheter Cardiovasc Interv       Date:  2019-04-29       Impact factor: 2.692

3.  Preliminary testing and evaluation of the renata minima stent, an infant stent capable of achieving adult dimensions.

Authors:  Evan M Zahn; Eason Abbott; Neil Tailor; Shyam Sathanandam; Dustin Armer
Journal:  Catheter Cardiovasc Interv       Date:  2021-05-04       Impact factor: 2.585

4.  Elastic stent recoil in coronary total occlusions: Comparison of durable-polymer zotarolimus eluting stent and ultrathin strut bioabsorbable-polymer sirolimus eluting stent.

Authors:  Riccardo Improta; Paola Scarparo; Jeroen Wilschut; Quinten Wolff; Joost Daemen; Wijnand K Den Dekker; Felix Zijlstra; Nicolas M Van Mieghem; Roberto Diletti
Journal:  Catheter Cardiovasc Interv       Date:  2021-05-07       Impact factor: 2.585

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.